Abstract
Introduction

MicroRNAs (miRNAs) are an abundant class of endogenous, single-stranded, small non-coding RNAs found in diverse organisms
. The number of verified human miRNAs is still expanding. They negatively regulate the translation of specific mRNAs by base pairing with partially or fully complementary sequences in target mRNAs [2] [3] [4] . Many miRNAs are evolutionarily conserved and have well-defined developmental and cell type specific expression patterns [5] . It is well known today that miRNAs have very impor-tumour suppressor genes [7, [22] [23] . Moreover, a few miRNAs may act at late stages of tumour progression, and the characteristic miRNA signatures in certain human cancers have revealed unique expression profiles [24] [25] [26] . However, which miRNAs are associated with, or regulate tumour progression remains unclear.
Our reported in our previous study on the potential oncofoetal biomarker desmin for colorectal cancer (CRC) [27] , provides support for the hypothesis that tumorigenesis and embryogenesis are postulated to share certain common pathways [28] [29] . For example, the increase in proliferation and the lack of differentiation of cancer cells resemble what occur in the embryonic stem cells during the physiological process of embryogenesis [30] . There are also striking similarities in the behaviour between invasive placental cells and invasive cancer cells [28] . The cellular mechanisms used by the cells of the placenta during implantation are reused by cancer cells during the invasiveness and metastasis within the body. In addition, miRNAs are necessary for stem cell division, cell fate determination and patterning in early and later stages of development, in which they regulate cell differentiation and maintain the pluripotent cell state [31] [32] . Overlapping expression of miRNAs in human embryonic colon and CRC were also found in the experimental study [30] . The sequences of many miRNAs are conserved among distantly related organisms, suggesting that these molecules participate in essential processes, including normal embryonic development and carcinogenesis [7, 33] . 
In the present study, microarrays were used to analyse the global expression of miRNAs in a human embryonic stem cell (hESC) line (i.e. HUES-17) and four CRC cell lines (i.e. LoVo, SW480, HT29 and Caco-2) with different metastatic potentialities. We postulate that hESCs and tumour metastasis cells, especially those with a high metastatic potentiality, may share some common endogenous miRNAs, and these miRNAs may modulate the expression of certain gene products of signalling pathways that are involved in both embryo implantation (or intestinal development) and progression in CRC.
Materials and methods
Cell culture
HUES-17, a hESC line, was provided by the Melton
Normalization and data analysis of microarray data
MiRNA microarray data were analysed by first subtracting the background and then normalizing the signals with a LOWESS filter (locally weighted regression) as described previously [36] . 
Cell migration and invasion assays
Cell migration and invasion were detected by using Transwell chambers (8 mm [40] and miRanda (http://www.microrna.org/) [41] have been employed to predict miRNA targets. In the present study, three discrete lists of the predicted targets were first generated by TargetScan, PicTar and miRanda. After the three lists were generated by the three computational programs, a fourth list was generated which contained only the genes predicted by the three initial computational programs.
Immunohistochemistry and histological examination
Differential genes between LoVo and NCM460 cell lines
Cells of a normal human colon epithelial cell line, NCM460, which was derived from non-transformed colonic epithelial cells [42] 
Intersection of genes between the differentially expressed genes between LoVo and NCM460 cell lines and the prediction of gene targets of miR-26b
Intersection of analyses of genes led to genes selected from the differentially expressed genes between LoVo and NCM460 cell lines and from the prediction of miRNA targets was carried out by TargetScan (http://www. targetscan.org/) [39] , PicTar (http://pictar.bio.nyu.edu.) [40] , and miRanda (http://www.microrna.org/) [41] . (Fig. S1) . In order to acquire the reliable and precise data on miRNAs, the total RNA was quantified and tested as a quality control for high quality RNA (Fig. 1) Fig. 3 ). (Fig. 4) . (Fig. 5) . Figure 6A .
Prediction and analysis of the genes and network pathways associated with metastasis
Confirmatory and validation studies on differentially expressed miRNA(s) by qRT-PCR
Fig. 2 Differentially expressed miRNAs. Differentially expressed patterns of miRNAs in the five different cell lines of HUES-17 (A), LoVo (B), SW480 (C), HT29 (D), Caco-2 (E).
Table 1 Eight miRNAs (miR-26b, miR-1246b, let-7e, miR-21, miR-196a, miR-16-2*, miR-1180 and miR-15b*) with the similar expression pattern between hESC and LoVo cell lines (LoVo with the highest potentiality of metastasis), but significantly different with the other three CRC cells: SW480, HT-29 and Caco-2 with the low potentiality of metastasis
Reporter name H17 (A) LOVO (B) SW480 (C) HT-29 (D) CACO-2 (E) AB (G2) CDE (G1) Log2 (G2/G1) P-value
To validate the microarray finding, miR-26b expression in CRC, adenoma and tumour adjacent 'normal' tissues collected from patients was determined by qRT-PCR. The level of miR-26b was lower in the CRC tissues (0.65 Ϯ 0.10) than in the 'normal' colorectal tissues (1.09 Ϯ 0.12). However, there was no significant difference in the miR-26b expression between the CRC and adenoma tissues
Effects of miR-26b mimics on human colorectal cancer cell proliferation and apoptosis in vitro
The fluorescence signal was observed in LoVo cells 48 hrs after the cells were transfected with the miR-26b mimics control as shown in
RT-PCR assay showed that miR-26b expression was significantly increased in miR-26b mimics-transfected cells when compared with the other three groups (miR-26b mimics control, liposome control and PBS control, Fig. 6B). No apparent increase in miR-26b expression was observed by simultaneous transfection of miR-26b mimics control.
In the clonogenic formation assay, upon 14-day continuous culture, the clone number in miR-26b mimics group was lower than that in the miR-26b mimics control group (Fig. 6C) . (Fig. 6D) . (Fig. 6F) . (Fig. 7B, left and right panels) . These necrotic areas were likely due to the aggressive nature of LoVo cells that rapidly outgrew other cancer cells and competed for blood supply and nutrients [44] . In contrast, tumours treated with miR-26b mimics contained large areas that were filled with necrotic cell debris (Fig. 7B, centre  panel) , and enlarged necrotic cores, which suggest that miR-26b inhibited cell proliferation and accelerated the cell death in tumour samples. The different necrotic degrees of tumours among the three groups are also shown in the gross pictures (Fig. 7B) .
In LoVo cells, miR-26b mimics induced apoptosis in 34.75% of cells, whereas the rates were 18.22% in PBS control group,
22.41% of liposome control group and 23.78% in mimics control groups
Effects of miR-26b on human colorectal cancer cell migration and invasion in vitro
Effects of miR-26b on tumour xenograft growth, cell proliferation and histological changes in vivo
To study the anti-tumorigenic role of miR-26b in CRC, immunodeficient BALB/C mice were subcutaneously inoculated with human LoVo colon cancer cells and housed until the tumour cells, initially loosely distributed in matrigel. Tumour was generated in all animals after inoculation of with human LoVo colon cancer cells. No death or signs of possible toxicity were observed during the study © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 4 Comparisons of miRNA-26b expression in tested cell lines by QRT-PCR. (A) Different cell lines, HUES-17, LoVo, Caco-2, HT-29 and SW480, are shown as each amplification curve for miR-26b. (B). After subtraction and normalization of the background, different levels of miR-26b are calculated by the ⌬CT method, and the relative expression levels are converted into 2 Ϫ⌬CT method as shown in the chart. The miR-26b expression levels between HUES-17 and LoVo cells are similar. There was no significant difference in miR-26b expression levels among Caco-2, HT-29 and SW480 cells. However, the levels of miR-26b are higher in SW480, HT-29, Caco-2 cells than those in HUES-17, and LoVo cells. Values represent the mean Ϯ S.D. of three independent
As shown in Figure 7B , the relative expression intensity of PCNA ϩ and CD31 ϩ cells in mice treated with miR-26b mimics were lower than in mice treated with PBS or miR-26b mimics control. In addition, no significant effects on proliferation were observed between PBS and control groups. (Fig. 8 ). Figure 9 , functional network analysis revealed that the (Fig. 9 ).
Prediction and validation of the gene targets of miR-26b
Prediction and analysis of the genes and network pathways associated with tumorigenesis and progression
Discussion
The [52] [53] . Interestingly, the expression of miR-26 family members have been shown to be induced by hypoxia [54] but down-regulated by exposure to cigarette smoke [55] . The Myc oncogene suppresses miR-26a, another member of the miR-26 family, which influences cell cycle progression by targeting the oncogene EZH2 in a murine lymphoma model [56] . Liver tumours with low miR-26 expression are distinct from those with high miR-26 expression in transcriptome activities and are associated with poor survival [57] . Many of the genes that are overexpressed in tumours with reduced miR-26 expression are related to cell immunity, such as those encoding pro-inflammatory and anti-inflammatory cytokines [57] . Moreover, many signalling networks that are activated in tumours with low miR-26 expression are immune-associated, such as NF-B-IL-6, IL-10 and STAT3 pathways [58] . Our results from the functional network analysis using the MetaCore database were in concert with these observations.
In 
